{
    "nctId": "NCT05491395",
    "briefTitle": "Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction",
    "officialTitle": "Randomized Phase III Clinical Trial of Hypofractionated Radiotherapy in Breast Cancer Patients With Immediate Prosthetic Reconstruction: PROMART Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Assess the G3 toxicity rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with confirmed histological diagnosis of invasive ductal carcinoma and lobular breast carcinoma;\n* Radical mastectomy with immediate reconstruction with a prosthesis;\n* Patients indicated for adjuvant RT;\n* Any lymph node status;\n* With or without adjuvant chemotherapy;\n* ECOG performance status from 0-2;\n* \\> 18 years old;\n* Informed Consent Form applied before any study-specific procedure.\n\nExclusion Criteria:\n\n* Another histological diagnosis than invasive ductal carcinoma or lobular carcinoma;\n* Previous history of neoplasm and/or radiotherapy and/ or quimiotherapy before this study;\n* Distant metastatic disease;\n* Palliative treatment;\n* Patients with scleroderma / systemic lupus erythematosus.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}